Terminology Service for NFDI4Health
VAdriaC-IE Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C67232
A regimen consisting of vincristine, doxorubicin and cyclophosphamide, alternating with ifosfamide and etoposide that can be used for the treatment of Ewing sarcoma and mesenchymal chondrosarcoma. [ ]
Term info
Label
VAdriaC-IE Regimen
Synonyms
- VAC-IE
- VAC/IE
- VAdriaC Alternating with IE
- VAdriaC-IE
- VAdriaC-IE Regimen
- VDC/IE
- VDC/IE Regimen
- Vincristine/Adriamycin/Cyclophosphamide-Ifosfamide/Etoposide Regimen
- Vincristine/Doxorubicin/Cyclophosphamide Alternating with Ifosfamide/Etoposide Regimen
- Vincristine/Doxorubicin/Cyclophosphamide-Ifosfamide/Etoposide Regimen
Subsets
NCIT_C160952, NCIT_C160950
Legacy Concept Name
VAdriaC-IE_Regimen
Preferred Name
VAdriaC-IE Regimen
Semantic Type
Therapeutic or Preventive Procedure
UMLS CUI
C1883515
code
C67232
Term relations
Subclass of:
- Regimen Used to Treat Ewing's Family of Tumors
- Chemotherapy_Regimen_Has_Component some Vincristine
- Chemotherapy_Regimen_Has_Component some Doxorubicin
- Regimen_Has_Accepted_Use_For_Disease some Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
- Chemotherapy_Regimen_Has_Component some Etoposide
- Chemotherapy_Regimen_Has_Component some Cyclophosphamide
- Chemotherapy_Regimen_Has_Component some Ifosfamide